Cidara Therapeutics Inc buy melinda
Start price
21.03.18
/
50%
€5.01
Target price
21.09.18
€7.31
Performance (%)
-25.23%
End price
21.09.18
€3.74
Summary
This prediction ended on 21.09.18 with a price of €3.74. The prediction for Cidara Therapeutics Inc disappointed with a performance of -25.23%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cidara Therapeutics Inc | - | - | - | - |
iShares Core DAX® | -0.922% | -1.078% | 12.165% | 16.796% |
iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% | 49.370% |
iShares Nikkei 225® | 2.224% | -2.825% | 19.015% | 4.643% |
iShares S&P 500 | -0.026% | -0.788% | 28.485% | 42.479% |
Comments by melinda for this prediction
In the thread Cidara Therapeutics Inc diskutieren
Biotechnologie und medizinische SecteurRecherche
Cidara Therapeutics, Inc.
Cidara Therapeutics stellt aktualisierte klinische Daten für seine Anti - Pilz - Blei rézafungine
(Laufzeit überschritten)
Stopped prediction by melinda for Cidara Therapeutics Inc
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€2.41
31.03.19
31.03.19
€2.71
04.11.21
04.11.21
-31.57%
22.06.21
22.06.21
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€9.59
19.03.16
19.03.16
€13.53
13.04.16
13.04.16
41.58%
13.04.16
13.04.16